NeuroLight Announces Corporate Restructuring to Accelerate Development of Prevention and Treatments for Alzheimer’s, PTSD, and Sleep DisordersDecember 12, 2025Read More »
NeuroLight Appoints Dr. Frank Nagy as Chief Clinical Officer and Director of Business DevelopmentOctober 1, 2025Read More »
NeuroLight Appoints Dr. Jumaah Goldberg as Chief Strategy Officer to Accelerate Commercialization of Breakthrough Brain State Transfer TechnologyAugust 14, 2025Read More »
Leading Medical Device Expert Dr. Manish Vaishya Joins NeuroLight’s Advisory Board to Advance Revolutionary Technology for Transplanting Brain StatesJune 28, 2025Read More »
NeuroLight Presents Groundbreaking Insights on Sleep Stage Transitions at ASCS 2025April 21, 2025Read More »
NeuroLight, Inc. Successfully Completes Phase I NSF/SBIR Grant, Paving the Way for Innovative Sleep TherapyJuly 1, 2024Read More »
US Patent Granted to NeuroLight for Technology to Induce Sleep by NeuromodulationJanuary 11, 2024Read More »
NeuroLight Has Been Awarded another US Patent on Technology to Enhance Emotional ResponseOctober 17, 2023Read More »
NeuroLight Has Been Awarded US Patent on Technology to Enhance Emotional ResponseAugust 10, 2023Read More »
NeuroLight Awarded Competitive Grant from the U.S. National Science FoundationNovember 15, 2022Read More »
